Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Cash & Cash Equivalents | 573,006 | 467,939 | 125,246 | 167,937 | 140,295 |
| Securities And Investments | 2,177,971 | 2,656,918 | 2,716,221 | 2,908,331 | 2,815,120 |
| Loans Gross | 7,694,712 | 7,968,947 | 8,441,402 | N/A | 9,015,459 |
| Allowance For Loan Losses | -343,443 | 0 | 0 | 0 | -208,365 |
| Receivables | N/A | N/A | N/A | 8,683,919 | N/A |
| PPE Net | 92,037 | 91,692 | 92,178 | 93,322 | 93,195 |
| Intangibles | 33,889 | 34,167 | 260,560 | 259,315 | 259,989 |
| Other assets | 649,248 | 653,827 | 764,173 | 706,806 | 675,027 |
| Total Assets | $10,877,420 | $11,873,490 | $12,399,780 | $12,819,630 | $12,790,720 |
| Liabilities | |||||
| Total deposits | 7,775,190 | 8,277,107 | 8,303,741 | 8,488,034 | 8,350,407 |
| Federal Funds Purchased | 1,049,146 | 1,092,968 | 1,096,130 | 1,222,162 | 1,163,023 |
| Short Term Debt | N/A | 248,280 | 248,278 | 248,277 | N/A |
| Long Term Debt | 248,281 | N/A | N/A | N/A | 248,276 |
| Other liabilities | 1,481,553 | 1,589,285 | 1,655,171 | 1,739,527 | 1,887,974 |
| Total Liabilities | $10,554,170 | $11,207,640 | $11,303,320 | $11,698,000 | $11,649,680 |
| Shareholders' Equity | |||||
| Preferred Shares | 294,136 | 293,614 | 293,084 | 292,524 | 291,964 |
| Common Shares | 962,874 | 52,398 | 52,397 | 52,400 | 52,134 |
| Additional Paid Capital | N/A | 910,535 | 909,850 | 909,586 | 909,386 |
| Retained earnings | -950,045 | -616,978 | -153,253 | -119,374 | -94,582 |
| Other shareholders' equity | 16,284 | 26,279 | -5,619 | -13,504 | -17,866 |
| TOTAL | $323,249 | $665,848 | $1,096,459 | $1,121,632 | $1,141,036 |
| Total Liabilities And Equity | $10,877,419 | $11,873,488 | $12,399,779 | $12,819,632 | $12,790,716 |